Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of July 19)

This week’s View covers articles about whether there is an association between the use of fluoroquinolones and an increased risk of aortic or mitral regurgitation; whether a new classification of response, based on reverse remodeling and the clinical composite score, better predicts survival after cardiac resynchronization therapy; and the clinical profiles, discharge medical therapies, and in-hospital mortality among patients hospitalized for heart failure across the spectrum of kidney function.